✦ LIBER ✦

Safety of regadenoson in patients with end-stage liver disease

✍ Scribed by Wael AlJaroudi; Fahad Iqbal; Jayanth Koneru; Pradeep Bhambhvani; Jaekyeong Heo; Ami E. Iskandrian

Book ID: 107650565
Publisher: Springer
Year: 2010
Tongue: English
Weight: 303 KB
Volume: 18
Category: Article
ISSN: 1071-3581
DOI: 10.1007/s12350-010-9288-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of invasive procedures in end-sta

Safety of invasive procedures in end-stage liver disease patients

✍ James D. Perkins 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

Patients with end-stage liver disease (ESLD) are predisposed to bleeding complications due to thrombocytopenia, reduced synthesis of coagulation factors, and increased fibrinolytic activity. The exact incidence of vascular access site and bleeding complications related to cardiac catheterization in

Efficacy and Safety of Atazanavir in Pat

Efficacy and Safety of Atazanavir in Patients with End-Stage Liver Disease

✍ G. Guaraldi; S. Cocchi; A. Motta; S. Ciaffi; M. Codeluppi; S. Bonora; F. Di Bene 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 236 KB

Cardiac catheterization in patients with

Cardiac catheterization in patients with end-stage liver disease: Safety and outcomes

✍ Jayasree Pillarisetti; Pavan Patel; Sowjanya Duthuluru; Jenny Roberts; Warren Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Left ventricular dyssynchrony in patient

Left ventricular dyssynchrony in patients with end-stage liver disease

✍ Wael AlJaroudi; Himanshu Aggarwal; Fahad Iqbal; Jaekyeong Heo; Ami E. Iskandrian 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 399 KB

Splanchnic hyperemia after liver transpl

Splanchnic hyperemia after liver transplantation in patients with end-stage liver disease

✍ Alvarez, Daniel ;Gerona, Solange ;Waisburg, Zulema ;Ciardullo, Miguel ;Santibañe 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 112 KB 👁 2 views

Systemic and splanchnic hemodynamic parameters were evaluated in 12 patients with cirrhosis before and 3 and 6 months after liver transplantation. Results were compared with those obtained in 8 healthy subjects. Three months after liver transplantation recipients had an increase in mean arterial pre

Feasibility and safety of percutaneous c

Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation

✍ Babak Azarbal; Paul Poommipanit; Boris Arbit; Antoine Hage; Jignesh Patel; Miche 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Percutaneous coronary intervention (PCI) has traditionally not been an option for patients with end-stage liver disease (ESLD) and coronary artery disease (CAD). This retrospective study was designed to demonstrate the feasibility and safety of PCI in liver transplant candidates. Patients with ESLD